Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

---

Publications & Presentations

11. Chang E, Ballard K E, Johnson P N, Nandyal R, Miller J L. Azithromycin for Eradication of Ureaplasma and Prevention of Bronchopulmonary Dysplasia in Preterm Neonates in the Neonatal Intensive Care Unit. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2023; 28 : 10-19

12. Hintze T D, Miller J L, Neely S, Lim S Y, Gupta N, Johnson P N. Characterization of early versus late opioid iatrogenic withdrawal syndrome in critically ill children transitioning from fentanyl -infusions to methadone. Journal of opioid management. 2023; 19 : 43-56

13. Stephens K, Miller J L, Harkin M, Neely S, Haws L, Johnson P N. Effect of Phytonadione on Correction of Coagulopathy in Pediatric Patients With Septic Shock. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2023; 28 : 423-429

14. Miller J L, Miller M M, Neely S, Medina M. Impact of Transitioning a Senior Seminar Capstone Course to an Intensive Hybrid Course. American journal of pharmaceutical education. 2023; 87 : ajpe8911

15. Bradford C, Miller J L, Harkin M, Chaaban H, Neely S, Johnson P N. Melatonin Use in Infants Admitted to Intensive Care Units. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2023; 28 : 635-642

Grants

1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.

Awards and Honors

1. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.


2. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.


3. Pediatric Pharmacy Association. Christensen Memorial Young Investigator Award Nominee (Resident Mentor). Date: 2022.


4. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2019.


5. University of Oklahoma College of Pharmacy; Department of Clinical and Administrative Sciences. Best Paper Award. Date: 2018.

Education

1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.


2. Degree: BS. Trevecca Nazarene University. Date: 2002.

Administrative Assignments

1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Read More